7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Neumora Therapeutics, Inc.
(NASDAQ:NMRA) 

NMRA stock logo

Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed.

Founded: 2019
IPO Price: $17 (Sep 15, 2023)
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends
Neumora Therapeutics . Op Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -2.78-2.38-1.98-1.59-1.19-0.79-0.40
Neumora Therapeutics . Free Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -2.78-2.38-1.98-1.59-1.19-0.79-0.40
Neumora Therapeutics . Cash Per Share ttm
202311 202312 202401 202402 202403 202404 01.563.124.686.247.89.3510.91
Neumora Therapeutics . (GAAP) P/E ratio ttm
202311 202312 202401 202402 202403 202404 -7.63-6.54-5.45-4.36-3.27-2.18-1.09-0
Neumora Therapeutics . P/B ratio ttm
202311 202312 202401 202402 202403 202404 00.230.470.70.941.171.411.64
No extra charts and metrics for this ticker.